Home » All » Stock Forecast » Apellis Pharmaceuticals Inc. Common Stock Forecast

Apellis Pharmaceuticals Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC
• 0.00%Market Cap $5.23B · Technical analysis Neutral · Focus area Price + volatility

Forecast Summary

TimeframePredicted PricePastHistoricalInsight
Tomorrow$40.66 -0.69%Yesterday$41.06 +0.29%Tomorrow's Apellis Pharmaceuticals Inc. Common Stock (APLS) setup is anchored to $40.94 and targets $40.66 (-0.69%). The near-term read is downside; watch $42.17 / $39.71 because daily realized volatility is about 3.57%.
Tomorrow's Apellis Pharmaceuticals Inc. Common Stock (APLS) setup is anchored to $40.94 and targets $40.66 (-0.69%). The near-term read is downside; watch $42.17 / $39.71 because daily realized volatility is about 3.57%.
Week$40.06 -2.16%Last Week$41.31 +0.91%The 7-day Apellis Pharmaceuticals Inc. Common Stock model moves from $41.31 to $40.06 (-2.16%). It gives downside momentum context for this stock, so breaks around $42.17 / $39.71 matter more than a single tick.
The 7-day Apellis Pharmaceuticals Inc. Common Stock model moves from $41.31 to $40.06 (-2.16%). It gives downside momentum context for this stock, so breaks around $42.17 / $39.71 matter more than a single tick.
Month$39.06 -4.59%Last Month$41.73 +1.93%The 1-month Apellis Pharmaceuticals Inc. Common Stock target is $39.06 (-4.59%), compared with the live reference near $40.94. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Apellis Pharmaceuticals Inc. Common Stock target is $39.06 (-4.59%), compared with the live reference near $40.94. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$37.57 -8.24%Last Year$42.36 +3.46%The 1-year Apellis Pharmaceuticals Inc. Common Stock scenario points to $37.57 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Apellis Pharmaceuticals Inc. Common Stock scenario points to $37.57 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$34.06 -16.80%5 Years Ago$43.83 +7.06%The 5-year Apellis Pharmaceuticals Inc. Common Stock view is $34.06 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Apellis Pharmaceuticals Inc. Common Stock view is $34.06 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Tomorrow$40.66 -0.69%
Yesterday$41.06 +0.29%
Tomorrow's Apellis Pharmaceuticals Inc. Common Stock (APLS) setup is anchored to $40.94 and targets $40.66 (-0.69%). The near-term read is downside; watch $42.17 / $39.71 because daily realized volatility is about 3.57%.
Week$40.06 -2.16%
Last Week$41.31 +0.91%
The 7-day Apellis Pharmaceuticals Inc. Common Stock model moves from $41.31 to $40.06 (-2.16%). It gives downside momentum context for this stock, so breaks around $42.17 / $39.71 matter more than a single tick.
Month$39.06 -4.59%
Last Month$41.73 +1.93%
The 1-month Apellis Pharmaceuticals Inc. Common Stock target is $39.06 (-4.59%), compared with the live reference near $40.94. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year$37.57 -8.24%
Last Year$42.36 +3.46%
The 1-year Apellis Pharmaceuticals Inc. Common Stock scenario points to $37.57 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years$34.06 -16.80%
5 Years Ago$43.83 +7.06%
The 5-year Apellis Pharmaceuticals Inc. Common Stock view is $34.06 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish
$41.85$41.20$40.55$39.90$39.251W AgoNow7D F

Technical Analysis

SellNeutralBuy
Bearish
0
Bullish
4
Neutral
1
Bearish

Key Indicators

IndicatorValueSignal
Price$40.94 Mid
Daily Change0.00% Mid
Volatility Cap20.0% Mid
Confidence57% Below
Data Sourcenasdaq-screener Mid

Historical Data

Current$40.94
Daily Change0.00%
Market Cap$5.23B
Sourcenasdaq-screener
Current$40.94Daily Change0.00%
Market Cap$5.23BSourcenasdaq-screener

Support & Resistance Levels

$39.71Support 1
$40.94Current
$42.17Resistance 1
i
Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context
Current$40.94Live reference price
Used as the anchor for generated forecast calculations.
Next Month$39.06Model projection-4.59%
Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed
57%
Directional
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.
Short term
57%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in APLS today
Bullish Scenario
$42.99
+5.00% from current
Target Price$42.99
ScenarioUpside momentum
Probability49%
Base Scenario
$39.06
-4.59%
Target Price$39.06
ScenarioCapped drift
Probability57%
Bearish Scenario
$38.89
-5.00% from current
Target Price$38.89
ScenarioVolatility drawdown
Probability43%
Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bearish · 40/100
24H drift-0.69%
7D drift-2.16%
30D drift-4.59%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-Off Caution · 35/100
1M outlook-4.59%
1Y outlook-8.24%
5Y outlook-16.80%

Frequently Asked Questions

Q What is the Apellis Pharmaceuticals Inc. Common Stock (APLS) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Apellis Pharmaceuticals Inc. Common Stock is projected near $40.66 versus the current reference around $40.94. That implies a modeled move of -0.69% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for APLS?
The weekly Apellis Pharmaceuticals Inc. Common Stock model points to $40.06, which maps to an expected drift of -2.16% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Apellis Pharmaceuticals Inc. Common Stock 1-month and 1-year targets?
The Apellis Pharmaceuticals Inc. Common Stock 1-month target is $39.06 (-4.59%), while the 1-year target is $37.57 (-8.24%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Apellis Pharmaceuticals Inc. Common Stock 5-year scenario differ from short-term rows?
The Apellis Pharmaceuticals Inc. Common Stock long-horizon scenario sits near $34.06 with a modeled change of -16.80%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are APLS support and resistance zones right now?
For Apellis Pharmaceuticals Inc. Common Stock, nearest resistance is around $39.71, while nearest support is around $42.17. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Apellis Pharmaceuticals Inc. Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.
Apellis Pharmaceuticals Inc. Common Stock Forecast 2026 – Tomorrow, Week & Month